Retroauricular subperiosteal vs systemic intravenous glucocorticoid administration on efficacy and blood glucose in diabetic patients with sudden deafness

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Diabetes. Jun 15, 2025; 16(6): 99602
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.99602

Table 2 The observation group shows significantly superior therapeutic efficacy than the control group, n (%)

Citation: Long J, Zuo HW. Retroauricular subperiosteal vs systemic intravenous glucocorticoid administration on efficacy and blood glucose in diabetic patients with sudden deafness. World J Diabetes 2025; 16(6): 99602
URL: https://www.wjgnet.com/1948-9358/full/v16/i6/99602.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i6.99602

Long J, Zuo HW. Retroauricular subperiosteal vs systemic intravenous glucocorticoid administration on efficacy and blood glucose in diabetic patients with sudden deafness. World J Diabetes 2025; 16(6): 99602 [PMID: 40548271 DOI: 10.4239/wjd.v16.i6.99602]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.